Matches in DBpedia 2015-10 for { ?s ?p "Epix Pharmaceuticals Inc (formerly Predix Pharmaceuticals Inc) was a pharmaceutical company based in Lexington, Massachusetts.Its products included the following agents: PRX-00023—5-HT1A receptor full agonist (later discovered to actually be an antagonist): for major depression and generalized anxiety disorder PRX-03140—5-HT4 receptor partial agonist: for Alzheimer's disease PRX-07034—5-HT6 receptor antagonist: for obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia PRX-08066—5-HT2B receptor antagonist: for pulmonary hypertension associated with chronic obstructive pulmonary diseaseAs of July 2009, the company was in the process of asset liquidation due to insufficient funds to stay afloat."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Epix_Pharmaceuticals abstract "Epix Pharmaceuticals Inc (formerly Predix Pharmaceuticals Inc) was a pharmaceutical company based in Lexington, Massachusetts.Its products included the following agents: PRX-00023—5-HT1A receptor full agonist (later discovered to actually be an antagonist): for major depression and generalized anxiety disorder PRX-03140—5-HT4 receptor partial agonist: for Alzheimer's disease PRX-07034—5-HT6 receptor antagonist: for obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia PRX-08066—5-HT2B receptor antagonist: for pulmonary hypertension associated with chronic obstructive pulmonary diseaseAs of July 2009, the company was in the process of asset liquidation due to insufficient funds to stay afloat.".
- Epix_Pharmaceuticals comment "Epix Pharmaceuticals Inc (formerly Predix Pharmaceuticals Inc) was a pharmaceutical company based in Lexington, Massachusetts.Its products included the following agents: PRX-00023—5-HT1A receptor full agonist (later discovered to actually be an antagonist): for major depression and generalized anxiety disorder PRX-03140—5-HT4 receptor partial agonist: for Alzheimer's disease PRX-07034—5-HT6 receptor antagonist: for obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia PRX-08066—5-HT2B receptor antagonist: for pulmonary hypertension associated with chronic obstructive pulmonary diseaseAs of July 2009, the company was in the process of asset liquidation due to insufficient funds to stay afloat.".